Mylan, Pfizer Unit Merger Clears Final Hurdle With FTC Deal
The Federal Trade Commission on Friday gave Mylan NV and Pfizer Inc.'s Upjohn off-patent brand and generic drug business the final antitrust approval they needed to complete their $12 billion merger,...To view the full article, register now.
Already a subscriber? Click here to view full article